Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

BACKGROUND: Chronic-active antibody mediated rejection (c-aABMR) is a major contributor to long-term kidney allograft loss. We conducted a retrospective analysis to establish the efficacy of treatment with intravenous immunoglobulins (IVIG) and pulse methylprednisolone (MP) of patients with c-aABMR....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Nephrol
Glavni autori: Sablik, Kasia A., Clahsen-van Groningen, Marian C., Looman, Caspar W. N., Damman, Jeffrey, van Agteren, Madelon, Betjes, Michiel G. H.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567552/
https://ncbi.nlm.nih.gov/pubmed/31200654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1385-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items